Meqsel 0.5mg Tablet contains Trametinib, a targeted cancer therapy used primarily in the treatment of melanoma with specific BRAF mutations. Trametinib is a MEK inhibitor that blocks the activity of MEK enzymes, which play a role in the growth and spread of cancer cells. This medication is often used in combination with other treatments to enhance therapeutic effects and improve outcomes for patients with advanced melanoma. It is essential to administer Meqsel under medical supervision to ensure the correct dosage and monitor any side effects.
Key Features:
- Contains 0.5mg of Trametinib, a potent MEK inhibitor
- Used for treating advanced melanoma with specific genetic mutations
- Inhibits cancer cell growth by targeting MEK enzymes
- Administered under medical guidance for optimal results
United States
United Kingdom
Australia
CN
Thailand
Meqsel+Rafinlar – Combination therapy. Ordered for my patient. Got delivery. Thanks.
Order for one our patient in Manipur. Easy to place order. They have store in Bangalore. My got to online pharmacy for my cancer patients.
Satisfied with their prompt response, delivery. Trusted and Recommended 👍